Immatics IMTX
NASDAQ IMTX
$7.72 +0.21 (+2.80%)
As of: Oct 21, 2026 · 11:41 AM EDT

Immatics (IMTX) Non-Current Debt (2019 - 2022)

Updated

Analysis

Immatics (IMTX) Non-Current Debt (2019 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 37.34 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 62.48 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 23.68 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 60.50 Bn
10 Immatics 942.08 Mn -1.08 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 32.42 Mn
Mar 31, 2022 28.77 Mn
Dec 31, 2021 45.54 Mn
Sep 30, 2021 45.91 Mn
Jun 30, 2021 12.91 Mn
Mar 31, 2021 13.74 Mn
Dec 31, 2020 35.60 Mn
Jun 30, 2020 11.21 Mn
Dec 31, 2019 9.38 Mn
API Access

Immatics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=IMTX&period=max&api_key=YOUR_API_KEY